Scholars Central

Conference abstractPublished 11 Jul 2016

What we should not do in COPD

Authors: Geertjan Wesseling

Maastricht UMC+, Netherlands

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic obstructive pulmonary disease causes signifi cant morbidity and mortality worldwide. Most patients can be treated in primary care. However, even in patients with relatively mild airfl ow obstruction referral to a specialist may lead to important fi ndings, both related to the COPD and to comorbidities. Several classifi cations and grading have been proposed throughout the years that help in categorizing patients, yet not all have direct consequences for the management, that typically includes lifestyle changes of which smoking cessation and increased physical activity or even rehabilitation are paramount and pharmacotherapy. Inhaled medication is aimed at improving expiratory fl ow, reducing hyperinfl ation and infl ammation to slow down disease progression and improve quality of life and prognosis. Long acting bronchodilators have clinically signifi cant eff ects and are widely used, also in mild to moderate disease. In recent years the Asthma COPD Overlap Syndrome has been proposed, which is a misnomer and oft en an excuse to skip an adequate diagnostic process and prescribe triple-therapy in patients who would do well with only one or two diff erent drugs. Unfortunately, the majority of COPD patients are on inhaled steroids but eff ects are small, oft en not clinically relevant and side eff ects such as an increased risk of pneumonia should warrant clinicians to be more prudent in prescribing those. Self management is considered an important component of management strategies, even if eff ects on various outcomes are limited. Repeated lung function measurements are oft en performed both in primary care and in the hospital with limited if any eff ects on management. Taken together, appropriate COPD management is not only about what we should do but certainly also about what we shouldnâÂ?Â?t.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pulmonary & Respiratory Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPulmonary & Respiratory Medicine
  • SubjectPulmonology & Respiratory
  • BylineArticles whose byline prints “Geertjan Wesseling”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels